Sarcopenia and anti-seizure medication response in juvenile myoclonic epilepsy.
epilepsy
magnetic resonance imaging
sarcopenia
Journal
Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837
Informations de publication
Date de publication:
Mar 2024
Mar 2024
Historique:
revised:
07
02
2024
received:
22
01
2024
accepted:
15
02
2024
medline:
12
3
2024
pubmed:
12
3
2024
entrez:
12
3
2024
Statut:
ppublish
Résumé
This study aimed to investigate the presence of sarcopenia in patients with juvenile myoclonic epilepsy (JME) and the association between sarcopenia and response to anti-seizure medication (ASM) in patients with JME. We enrolled 42 patients with JME and 42 healthy controls who underwent brain magnetic resonance imaging with three-dimensional T1-weighted imaging. We measured the temporal muscle thickness (TMT), a radiographic marker for sarcopenia, using T1-weighted imaging. We compared the TMT between patients with JME and healthy controls and analyzed it according to the ASM response in patients with JME. We also performed a receiver operating characteristic (ROC) curve analysis to evaluate how well the TMT differentiated the groups. The TMT in patients with JME did not differ from that in healthy controls (9.630 vs. 9.956 mm, p = .306); however, ASM poor responders had a lower TMT than ASM good responders (9.109 vs. 10.104 mm, p = .023). ROC curve analysis revealed that the TMT exhibited a poor performance in differentiating patients with JME from healthy controls, with an area under the ROC curve of .570 (p = .270), but good performance in differentiating between ASM good and poor responders, with an area under the ROC curve of .700 (p = .015). The TMT did not differ between patients with JME and healthy controls; however, it was reduced in ASM poor responders compared to ASM good responders, suggesting a link between ASM response and sarcopenia in patients with JME. TMT can be used to investigate sarcopenia in various neurological disorders.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e3464Subventions
Organisme : Korea Health Industry Development Institute (KHIDI)
Organisme : Ministry of Health & Welfare, Republic of Korea
ID : HR21C1003
Informations de copyright
© 2024 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
Références
Bakhtadze, S., Geladze, N., & Khachapuridze, N. (2021). Inflammation in childhood epilepsy syndromes. Georgian Medical News, Mar(312), 88-92.
Bozzetti, F. (2017). Forcing the vicious circle: Sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy. Annals of Oncology, 28(9), 2107-2118. https://doi.org/10.1093/annonc/mdx271
Brodie, M. J., Barry, S. J. E., Bamagous, G. A., Norrie, J. D., & Kwan, P. (2012). Patterns of treatment response in newly diagnosed epilepsy. Neurology, 78(20), 1548-1554. https://doi.org/10.1212/WNL.0b013e3182563b19
Cai, Y., Feng, F., Wei, Q., Jiang, Z., Ou, R., & Shang, H. (2021). Sarcopenia in patients with Parkinson's disease: A systematic review and meta-analysis. Frontiers in Neurology, 12, 598035. https://doi.org/10.3389/fneur.2021.598035
Cho, J., Park, M., Moon, W.-J., Han, S.-H., & Moon, Y. (2022). Sarcopenia in patients with dementia: Correlation of temporalis muscle thickness with appendicular muscle mass. Neurological Sciences, 43(5), 3089-3095. https://doi.org/10.1007/s10072-021-05728-8
Choi, J., & Koh, S. (2008). Role of brain inflammation in epileptogenesis. Yonsei Medical Journal, 49(1), 1-18. https://doi.org/10.3349/ymj.2008.49.1.1
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., Schneider, S. M., Sieber, C. C., Topinkova, E., Vandewoude, M., Visser, M., Zamboni, M., Bautmans, I., Baeyens, J.-P., Cesari, M., … the Extended Group for EWGSOP2. (2019). Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing, 48(1), 16-31. https://doi.org/10.1093/ageing/afy169
Cruz-Jentoft, A. J., & Sayer, A. A. (2019). Sarcopenia. Lancet, 393(10191), 2636-2646. https://doi.org/10.1016/s0140-6736(19)31138-9
Garry, P. J., & Chumlea, W. C. (1989). Epidemiologic and methodologic problems in determining nutritional status of older persons. Proceedings of a conference. Albuquerque, New Mexico, October 19-21, 1988. The American Journal of Clinical Nutrition, 50, (5 Suppl), 1121-1235.
Fedorov, A., Beichel, R., Kalpathy-Cramer, J., Finet, J., Fillion-Robin, J.-C., Pujol, S., Bauer, C., Jennings, D., Fennessy, F., Sonka, M., Buatti, J., Aylward, S., Miller, J. V., Pieper, S., & Kikinis, R. (2012). 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magnetic Resonance Imaging, 30(9), 1323-1341. https://doi.org/10.1016/j.mri.2012.05.001
Hirsch, E., French, J., Scheffer, I. E., Bogacz, A., Alsaadi, T., Sperling, M. R., Abdulla, F., Zuberi, S. M., Trinka, E., Specchio, N., Somerville, E., Samia, P., Riney, K., Nabbout, R., Jain, S., Wilmshurst, J. M., Auvin, S., Wiebe, S., Perucca, E., … Wirrell, E. C. (2022). ILAE definition of the idiopathic generalized epilepsy syndromes: Position statement by the ILAE task force on nosology and definitions. Epilepsia, 63(6), 1475-1499. https://doi.org/10.1111/epi.17236
Huq, S., Khalafallah, A. M., Ruiz-Cardozo, M. A., Botros, D., Oliveira, L. A. P., Dux, H., White, T., Jimenez, A. E., Gujar, S. K., Sair, H. I., Pillai, J. J., & Mukherjee, D. (2021). A novel radiographic marker of sarcopenia with prognostic value in glioblastoma. Clinical Neurology and Neurosurgery, 207, 106782. https://doi.org/10.1016/j.clineuro.2021.106782
Jang, H., Lee, J. Y., Lee, K. I., & Park, K. M. (2017). Are there differences in brain morphology according to handedness? Brain and Behavior, 7(7), e00730. https://doi.org/10.1002/brb3.730
Jang, H. C. (2018). How to diagnose sarcopenia in Korean older adults? Annals of Geriatric Medicine and Research, 22(2), 73-79. https://doi.org/10.4235/agmr.2018.22.2.73
Khurana, D. S., Valencia, I., Goldenthal, M. J., & Legido, A. (2013). Mitochondrial dysfunction in epilepsy. Seminars in Pediatric Neurology, 20(3), 176-187. https://doi.org/10.1016/j.spen.2013.10.001
Kikinis, R., & Pieper, S. (2011). 3D Slicer as a tool for interactive brain tumor segmentation. Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2011, 6982-6984. https://doi.org/10.1109/IEMBS.2011.6091765
Koike, C., Lima, E. M., Paiva, M. L., Pentagna, A., Bimbatti, I., & Valente, K. D. (2023). Sleep quality and circadian rhythm profile of persons with juvenile myoclonic epilepsy in a tertiary epilepsy center: A case-control study. Seizure, 104, 1-5. https://doi.org/10.1016/j.seizure.2022.11.002
Kwan, P., Arzimanoglou, A., Berg, A. T., Brodie, M. J., Allen Hauser, W., Mathern, G., Moshé, S. L., Perucca, E., Wiebe, S., & French, J. (2010). Definition of drug resistant epilepsy: Consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia, 51(6), 1069-1077. https://doi.org/10.1111/j.1528-1167.2009.02397.x
Lin, J., Zhang, W., Chen, W., Huang, Y., Wu, R., Chen, X., Shen, X., & Zhu, G. (2019). Muscle mass, density, and strength are necessary to diagnose sarcopenia in patients with gastric cancer. Journal of Surgical Research, 241, 141-148. https://doi.org/10.1016/j.jss.2019.03.022
Mcnamara, N. A., Romanowski, E. M. F., Olson, D P., & Shellhaas, R. A. (2017). Bone health and endocrine comorbidities in pediatric epilepsy. Seminars in Pediatric Neurology, 24(4), 301-309. https://doi.org/10.1016/j.spen.2017.10.005
Miles, M. V., Miles, L., Horn, P. S., & Degrauw, T. J. (2012). Enzyme inducing antiepileptic drugs are associated with mitochondrial proliferation and increased cytochrome c oxidase activity in muscle of children with epilepsy. Epilepsy Research, 98(1), 76-87. https://doi.org/10.1016/j.eplepsyres.2011.08.018
Pana, A., Sourtzi, P., Kalokairinou, A., & Velonaki, V. S. (2022). Sarcopenia and polypharmacy among older adults: A scoping review of the literature. Archives of Gerontology and Geriatrics, 98, 104520. https://doi.org/10.1016/j.archger.2021.104520
Petermann-Rocha, F., Balntzi, V., Gray, S R., Lara, J., Ho, F. K., Pell, J. P., & Celis-Morales, C. (2022). Global prevalence of sarcopenia and severe sarcopenia: A systematic review and meta-analysis. Journal of Cachexia, Sarcopenia and Muscle, 13(1), 86-99. https://doi.org/10.1002/jcsm.12783
Prado, C. M. M., Baracos, V. E., Mccargar, L. J., Reiman, T., Mourtzakis, M., Tonkin, K., Mackey, J. R., Koski, S., Pituskin, E., & Sawyer, M B. (2009). Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clinical Cancer Research, 15(8), 2920-2926. https://doi.org/10.1158/1078-0432.CCR-08-2242
Prado, C. M., Cushen, S. J., Orsso, C. E., & Ryan, A. M. (2016). Sarcopenia and cachexia in the era of obesity: Clinical and nutritional impact. Proceedings of the Nutrition Society, 75(2), 188-198. https://doi.org/10.1017/S0029665115004279
Prokopidis, K., Giannos, P., Reginster, J. Y., Bruyere, O., Petrovic, M., Cherubini, A., Triantafyllidis, K. K., Kechagias, K. S., Dionyssiotis, Y., Cesari, M., Ibrahim, K., Scott, D., Barbagallo, M., Veronese, N., & Special interest group in Systematic Reviews and Meta-analyses and the Task Force on Pharmaceutical Strategy of the European Geriatric Medicine Society. (2023). Sarcopenia is associated with a greater risk of polypharmacy and number of medications: A systematic review and meta-analysis. Journal of Cachexia, Sarcopenia and Muscle, 14(2), 671-683. https://doi.org/10.1002/jcsm.13190
Ranganathan, K., Terjimanian, M., Lisiecki, J., Rinkinen, J., Mukkamala, A., Brownley, C., Buchman, S R., Wang, S. C., & Levi, B. (2014). Temporalis muscle morphomics: The psoas of the craniofacial skeleton. Journal of Surgical Research, 186(1), 246-252. https://doi.org/10.1016/j.jss.2013.07.059
Ryan, A. M., Prado, C. M., Sullivan, E. S., Power, D. G., & Daly, L. E. (2019). Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival. Nutrition, 67-68(68), 110539. https://doi.org/10.1016/j.nut.2019.06.020
Ryan, A. S., Ivey, F. M., Serra, M. C., Hartstein, J., & Hafer-Macko, C. E. (2017). Sarcopenia and physical function in middle-aged and older stroke survivors. Archives of Physical Medicine and Rehabilitatio, 98(3), 495-499. https://doi.org/10.1016/j.apmr.2016.07.015
Simm, P. J., Seah, S., Gorelik, A., Gilbert, L., Nuguid, J., Werther, G. A., Mackay, M. T., Freeman, J. L., Petty, S. J., & Wark, J. D. (2017). Impaired bone and muscle development in young people treated with antiepileptic drugs. Epilepsia, 58(11), 1931-1938. https://doi.org/10.1111/epi.13893
Singh, S., & Singh, T. G. (2021). Emerging perspectives on mitochondrial dysfunctioning and inflammation in epileptogenesis. Journal of Inflammation Research, 70(10-12), 1027-1042. https://doi.org/10.1007/s00011-021-01511-9
Smith, L., Shin, J. I., Veronese, N., Soysal, P., Lopez Sanchez, G. F., Pizzol, D., & Koyanagi, A. (2022). Sleep duration and sarcopenia in adults aged >/= 65 years from low and middle-income countries. Aging Clinical and Experimental Research, 34(7), 1573-1581. https://doi.org/10.1007/s40520-022-02074-3
Srdic, D., Plestina, S., Sverko-Peternac, A., Nikolac, N., Simundic, A.-M., & Samarzija, M. (2016). Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value. Supportive Care in Cancer, 24(11), 4495-4502. https://doi.org/10.1007/s00520-016-3287-y
Steindl, A., Leitner, J., Schwarz, M., Nenning, K.-H., Asenbaum, U., Mayer, S., Woitek, R., Weber, M., Schöpf, V., Berghoff, A. S., Berger, T., Widhalm, G., Prayer, D., Preusser, M., & Furtner, J. (2020). Sarcopenia in neurological patients: Standard values for temporal muscle thickness and muscle strength evaluation. Journal of Clinical Medicine, 9(5), 1272. https://doi.org/10.3390/jcm9051272
Syvertsen, M., Hellum, M. K., Hansen, G., Edland, A., Nakken, K. O., Selmer, K. K., & Koht, J. (2017). Prevalence of juvenile myoclonic epilepsy in people <30 years of age-A population-based study in Norway. Epilepsia, 58(1), 105-112. https://doi.org/10.1111/epi.13613
Waldbaum, S., & Patel, M. (2010). Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Research, 88(1), 23-45. https://doi.org/10.1016/j.eplepsyres.2009.09.020
Wheelwright, S., Darlington, A.-S., Hopkinson, J. B., Fitzsimmons, D., White, A., & Johnson, C. D. (2013). A systematic review of health-related quality of life instruments in patients with cancer cachexia. Supportive Care in Cancer, 21(9), 2625-2636. https://doi.org/10.1007/s00520-013-1881-9
Wooles, N. R., Bell, P. R., & Korda, M. (2014). Traumatic rupture of sternocleidomastoid muscle following an epileptic seizure. BMJ Case Reports, 2014, bcr2014205531. https://doi.org/10.1136/bcr-2014-205531
Xu, X., & Wen, Z. (2023). The mediating role of inflammaging between mitochondrial dysfunction and sarcopenia in aging: A review. American Journal of Clinical and Experimental Immunology, 12(6), 109-126.
Yang, J., Jiang, F., Yang, M., & Chen, Z. (2022). Sarcopenia and nervous system disorders. Journal of Neurology, 269(11), 5787-5797. https://doi.org/10.1007/s00415-022-11268-8